SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are experiencing strong momentum driven by robust first-quarter earnings that surpassed revenue and profitability estimates, fueling a wave of analyst price target upgrades. The community is actively discussing the company's platform growth, its milestone of exceeding 100 million active households, and continued speculation regarding potential acquisition interest from major media companies.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is trending as a key player in the decentralized AI sector, driven by a structural narrative that positioning it as a permissionless, global alternative to the increasingly restricted and centralized AI models offered by big tech. The community is actively debating the network's long-term utility versus its risks, while many are focused on the integration of subnets and the broader potential of decentralizing AI infrastructure.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors weigh strong Phase 3 clinical data for its gene-editing HAE therapy against a recent equity offering, which has sparked intense debate over dilution and potential short-squeeze dynamics. The community remains focused on the company's long-term commercial potential, institutional accumulation, and whether the recent capital raise serves as a strategic runway or a near-term headwind.

Tidal Trust II - Defiance Daily Target 2X Short ASTS ETF

ASTN is gaining attention as traders utilize the leveraged inverse ETF to bet against the volatility and high-profile hype surrounding ASTS. Community sentiment is deeply polarized, with participants actively debating whether to capitalize on potential price pullbacks or remain long in a stock frequently cited as a meme-driven opportunity.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is seeing heightened engagement as investors react to Cathie Wood's aggressive portfolio rebalancing, specifically her significant accumulation of SpaceX shares and shifts away from legacy biotech and semiconductor holdings. Community debate remains polarized, with many users criticizing the fund's historical underperformance and high fees while others highlight its structural role in providing exposure to speculative, high-volatility innovation themes.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery shareholders are preparing to vote on the proposed $110 billion merger with Paramount Skydance, a deal that has received unanimous board support despite significant pushback from Hollywood creators and industry figures concerned about media consolidation. The community is closely watching the vote for clarity on the merger's path forward, as well as the controversy surrounding the CEO's substantial compensation package and ongoing regulatory scrutiny.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing heightened volatility as investors debate its long-term viability amidst broader cryptocurrency market pressure and speculation surrounding potential ties to Elon Musk's companies. While some community members remain optimistic, citing previous support levels and future catalysts, others express skepticism, viewing the recent price action as a sign of fading momentum.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is drawing attention as a potential M&A target amid ongoing market speculation, with investors closely watching institutional activity and the company's aggressive pipeline expansion. Community sentiment remains focused on the drug's long-term commercial potential and the likelihood of a high-premium buyout as institutional investors weigh growth versus profitability.

PolySwarm

PolySwarm ($NCT) is capturing community attention due to its extremely low float and persistent chatter about its potential for momentum-driven price action in the cybersecurity sector. Investors are closely monitoring the token's technical consolidation and tight price action, with many discussing its long-term utility while actively looking for signs of a significant breakout.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup Co. is currently trending as a polarizing value play, with retail investors divided between viewing it as an oversold defensive dividend opportunity or a struggling legacy brand facing margin compression and high leverage. The community is closely monitoring upcoming earnings and potential M&A speculation, as sentiment remains cautious due to intense short interest and ongoing sector-wide headwinds like changing consumer preferences.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Humana Closes the Kindred Chapter With $900 Million Gentiva Exit

HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.

Humana To Sell Gentiva Minority Stake In $900 Mln Deal

(RTTNews) - Humana Inc. (HUM) announced that it has entered into a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, a provider of end-of-life services including hospice and palliative care. The agreement v...

Humana Announces Agreement to Divest Minority Interest in Gentiva

Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nations leading provider of end-of-life services, including hospice and palliative care. The agreement values...

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would...

UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too?

UNH has surged 20% this year, but with valuation rising and investigations ongoing, is the easy money already gone?

UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose

UNH raises its dividend again, extending a long streak of annual increases despite a smaller hike.

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina 

UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.

5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation  

Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.

Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?

UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM PR Newswire NEW ORLEANS, May 29, 2026 NEW...

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Current Price	$379.22
Prev Close	$368.69
Open	$370.74
Dividend Yield	1.38%
50-Day Moving Average	$267.51
Beta	0.35
Avg. Volume	1.62M
PE Ratio	40.58

52-Week High	$379.50
52-Week Low	$163.11
Market Capitalization	$45.53B
EPS (Annual)	$9.83
Price to Book	2.45
Revenue Per Employee	$1.93M

HUMHumana Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HUM News